Ngā hua rapu - Mauro Schechter

Whakamahine hua
  1. 1
    Therapy for Early HIV Infection: How Far Back Should the Pendulum Swing?

    Therapy for Early HIV Infection: How Far Back Should the Pendulum Swing? mā Mauro Schechter

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Treatment at scale in Brazil: a physician's perspective

    Treatment at scale in Brazil: a physician's perspective mā Mauro Schechter

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Prioritization of antiretroviral therapy in patients with high CD4 counts, and retention in care: lessons from the START and Temprano trials

    Prioritization of antiretroviral therapy in patients with high CD4 counts, and retention in care: lessons from the START and Temprano trials mā Mauro Schechter

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    V3 peptide binding pattern and HIV-1 transmission route in Rio de Janeiro

    V3 peptide binding pattern and HIV-1 transmission route in Rio de Janeiro mā Mónica Pinto, Mauro Schechter

    I whakaputaina 1995
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    The DART Trial: 'The Doctor's Dilemma' revisited

    The DART Trial: 'The Doctor's Dilemma' revisited mā Estêvão Portela Nunes, Beatriz Grinsztejn, Mauro Schechter

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Protease inhibitors as initial therapy for individuals with an intermediate risk of HIV disease progression: is more necessarily better?

    Protease inhibitors as initial therapy for individuals with an intermediate risk of HIV disease progression: is more necessarily better? mā Mauro Schechter, Cláudio J. Struchiner, Lee H. Harrison

    I whakaputaina 1999
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Effectiveness of Antiretroviral Therapy Among Patients Who Attend Public HIV Clinics in Rio de Janeiro, Brazil

    Effectiveness of Antiretroviral Therapy Among Patients Who Attend Public HIV Clinics in Rio de Janeiro, Brazil mā Cristina Barroso Hofer, Mauro Schechter, Lee H. Harrison

    I whakaputaina 2004
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Association Between Male Circumcision and Prevalent HIV Infections in Rio de Janeiro, Brazil

    Association Between Male Circumcision and Prevalent HIV Infections in Rio de Janeiro, Brazil mā ANDRÉ R. S. PÉRISSÉ, Mauro Schechter, William A. Blattner

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Antiretroviral therapy in resource-poor settings: scaling up inequalities?

    Antiretroviral therapy in resource-poor settings: scaling up inequalities? mā Matthias Egger, Andrew Boulle, Mauro Schechter, Paolo Miotti

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    HIV Viral Load and CD4+ Lymphocyte Counts in Subjects Coinfected With HTLV-I and HIV-1

    HIV Viral Load and CD4+ Lymphocyte Counts in Subjects Coinfected With HTLV-I and HIV-1 mā Mauro Schechter, Lawrence H. Moulton, Lee H. Harrison

    I whakaputaina 1997
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Rating evidence in treatment guidelines

    Rating evidence in treatment guidelines mā Caroline Sabin, David A. Cooper, Simon Collins, Mauro Schechter

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals

    Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals mā Sunpeng Wang, Patricia Lima Hottz, Mauro Schechter, Libin Rong

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Mortality of HIV-infected patients in low-income countries – Authors’ response

    Mortality of HIV-infected patients in low-income countries – Authors’ response mā Martin W. G. Brinkhof, Matthias Egger, Mauro Schechter, François Dabis

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Could well-established, widely available, and simple laboratory techniques explain a laboratory origin of SARS-CoV-2?

    Could well-established, widely available, and simple laboratory techniques explain a laboratory origin of SARS-CoV-2? mā Robert M. Lloyd, James Hunter, Ricardo Sobhie Diaz, Mauro Schechter

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs

    Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs mā Frederick L. Altice, Adeeba Kamarulzaman, Vincent Soriano, Mauro Schechter, Gerald Friedland

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil

    Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil mā Ana M. F. de Pinho, Guilherme Santoro‐Lopes, Lee H. Harrison, Mauro Schechter

    I whakaputaina 2001
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Predictors of Virologic Failure in HIV-1-Infected Patients Starting Highly Active Antiretroviral Therapy in Porto Alegre, Brazil

    Predictors of Virologic Failure in HIV-1-Infected Patients Starting Highly Active Antiretroviral Therapy in Porto Alegre, Brazil mā Suely Tuboi, Lee H. Harrison, Eduardo Sprinz, Ricardo Kerti Mangabeira Albernaz, Mauro Schechter

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Increase in Non-AIDS Related Conditions as Causes of Death among HIV-Infected Individuals in the HAART Era in Brazil

    Increase in Non-AIDS Related Conditions as Causes of Death among HIV-Infected Individuals in the HAART Era in Brazil mā Antônio Guilherme Pacheco, Suely Tuboi, José Cláudio Faulhaber, Lee H. Harrison, Mauro Schechter

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Reduced Risk of Tuberculosis among Brazilian Patients with Advanced Human Immunodeficiency Virus Infection Treated with Highly Active Antiretroviral Therapy

    Reduced Risk of Tuberculosis among Brazilian Patients with Advanced Human Immunodeficiency Virus Infection Treated with Highly Active Antiretroviral Therapy mā Guilherme Santoro‐Lopes, Ana Maria Felix de Pinho, Lee H. Harrison, Mauro Schechter

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Achieving Viral Suppression in 90% of People Living With Human Immunodeficiency Virus on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities

    Achieving Viral Suppression in 90% of People Living With Human Immunodeficiency Virus on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Oppor... mā Jean B. Nachega, Nadia A. Sam‐Agudu, Lynne Mofenson, Mauro Schechter, John W. Mellors

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: